Singapore markets close in 23 minutes

Vyant Bio, Inc. (VYNT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1700+0.0030 (+1.80%)
At close: 12:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.08M
Enterprise value -6.77M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)1.50
Price/book (mrq)0.11
Enterprise value/revenue -10.16
Enterprise value/EBITDA 0.45

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 3-93.51%
S&P500 52-week change 316.57%
52-week high 33.0000
52-week low 30.1410
50-day moving average 30.1885
200-day moving average 30.4443

Share statistics

Avg vol (3-month) 329.29k
Avg vol (10-day) 335.34k
Shares outstanding 56.33M
Implied shares outstanding 66.33M
Float 85.1M
% held by insiders 118.77%
% held by institutions 14.49%
Shares short (27 Apr 2023) 4204.71k
Short ratio (27 Apr 2023) 41.8
Short % of float (27 Apr 2023) 43.55%
Short % of shares outstanding (27 Apr 2023) 43.27%
Shares short (prior month 30 Mar 2023) 4179.07k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 324 Oct 2019
Ex-dividend date 4N/A
Last split factor 21:5
Last split date 301 Nov 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin 0.00%
Operating margin (ttm)-3,445.84%

Management effectiveness

Return on assets (ttm)-51.76%
Return on equity (ttm)-122.41%

Income statement

Revenue (ttm)397k
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)-27.90%
Gross profit (ttm)N/A
EBITDA -13.28M
Net income avi to common (ttm)-13.03M
Diluted EPS (ttm)-2.7900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.8M
Total cash per share (mrq)0.44
Total debt (mrq)708k
Total debt/equity (mrq)15.73%
Current ratio (mrq)2.86
Book value per share (mrq)0.71

Cash flow statement

Operating cash flow (ttm)-12.96M
Levered free cash flow (ttm)-9.42M